Study of Safety of Medicinal Products in Pregnant Women in Crimea

2022-01-08T21:32:42+03:00

A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva https://doi.org/10.30895/2312-7821-2021-9-2-95-102 ABSTRACT According to international epidemiological studies, about 80% of women have to use medicinal products during pregnancy, mainly during the first weeks of organogenesis in the case of an unplanned pregnancy, and for the treatment of chronic diseases or acute conditions [...]

Study of Safety of Medicinal Products in Pregnant Women in Crimea2022-01-08T21:32:42+03:00

Gender peculiarities in the development of adverse reactions of medicinal products

2021-11-17T16:58:01+03:00

Matveev A.V., Krasheninnikov A.E., Egorova E.A., Konyaeva E.I., Bekirova E.Yu.National Scientific Center for Pharmacovigilance, S.I. Georgievsky Medical Academy of the Crimean Federal University named after V.I. Vernadsky, Moscow, Simferopol. At the present stage of healthcare development, the study of gender peculiarities of the onset and course of various diseases, as well as the variability [...]

Gender peculiarities in the development of adverse reactions of medicinal products2021-11-17T16:58:01+03:00

Retrospective analysis of adverse reactions to penicillin-type antibiotics using the drug problem system method

2021-11-13T20:16:17+03:00

The results of the analysis of ADR cards revealed that amoxicillin-clavulanate and amoxicillin were the "leading" drugs in terms of the frequency of ADR development. It is worth noting the high incidence of ADR development against the background of penicillin use in pediatric patients (from 0 to 18 years) 142 cases.

Retrospective analysis of adverse reactions to penicillin-type antibiotics using the drug problem system method2021-11-13T20:16:17+03:00

Цель Центра по фармаконадзору

Целью организации является развитие системы фармаконадзора, защита здоровья населения, мониторинг безопасности лекарственных средств, анализ, оценка риска использования лекарственных средств, медицинских изделий, развитие образования и науки в области фармаконадзора и безопасности лекарственных средств, а также содействие развитию системы фармаконадзора на территории Евразийского экономического союза.

КОНТАКТНАЯ ИНФОРМАЦИЯ

  • Российская Федерация. Москва. ул. Бауманская 6, стр. 2
  • 8-800-777-86-04

УСЛУГИ ПО ФАРМАКОНАДЗОРУ

Страница участника Сколково

АНО «Национальный научный центр Фармаконадзора» является резидентом инновационного фонда «Сколково» с 2018 года

© Copyright 2017 -    |   Все права защищены   
Go to Top